NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-187-1995-1-JP-07 PRODUCTION OF ATTENUATED PARAINFLUENZA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES JP DIV 2007-013809 Abandoned
NIA E-262-2003-0-US-03 Uses of Notch Receptors, Notch Ligands, and Notch Modulators in Methods Related to Metabolic Diseases US National Stage 11/658,189 7888116 Abandoned PDF
NCI E-286-2007-0-PCT-01 Methods for increasing Levels of Human Fetal Hemoglobin PCT PCT PCT/US2007/001328 Expired
NICHD E-027-2006-0-PCT-02 Identification Of Inactivating Mutations Of The PDE11A Gene In A Form Of Micronodular Adrenocortical Hperplasis, An Inherited Form Of Cushing Syndrome PCT PCT PCT/US2007/060746 Abandoned
NCI E-228-2003-1-PCT-02 SOLUBLE FRAGMENTS OF THE SARS-COV SPIKE GLYCOPROTEIN PCT PCT PCT/US2007/001270 Expired
NCI E-228-2003-1-EP-06 Soluble Forms Of The SARS Virus S Protein EP National Stage 07718249.1 Abandoned
NCI E-228-2003-1-CN-05 SOLUBLE FRAGMENTS OF THE SARS-COV SPIKE GLYCOPROTEIN CN National Stage 200780002688.5 Abandoned
NCI E-228-2003-1-CA-04 Soluble Forms Of The SARS Virus S Protein CA National Stage 2637730 Abandoned
NCI E-228-2003-1-AU-03 Soluble Forms Of The SARS Virus S Protein AU National Stage 2007207559 Abandoned
NCI E-059-2007-1-US-01 Identification And Characterization Of A Mouse T Cell Receptor Recognizing HLA-A*0201 Restricted Human Melanoma Antigen Gp100154-162 US 60/885,724 Abandoned
NICHD E-096-2007-0-US-01 Method for Predicting and Detecting Tumor Metastasis US 60/885,809 Abandoned
NIDDK E-229-2006-0-US-01 An O-GlcNAcase- Specific Inhibitor and Substrate Engineered by the Extension of the N-Acetyl Moiety US ORD 11/654,647 Abandoned
NIAID E-031-2006-0-EP-04 Chlamydia Vaccine EP National Stage 07717780.6 Abandoned
NIAID E-031-2006-0-DE-06 Chlamydia Vaccine DE EP 07717780.6 Abandoned
NIAID E-031-2006-0-FR-07 Chlamydia Vaccine FR EP 07717780.6 Abandoned
NIAID E-031-2006-0-GB-08 Chlamydia Vaccine GB EP 07717780.6 Abandoned
NIAID E-031-2006-0-PCT-02 Chlamydia Vaccine PCT PCT PCT/US2007/001213 Expired
NIAID E-267-2004-1-US-08 VACCINES AGAINST AIDS COMPRISING CMV/R-NUCLEIC ACID CONSTRUCTS US National Stage 11/632,522 Abandoned
NCI E-085-2007-0-US-01 Methods of Determining the Prognosis of an Adenocarcinoma US 60/885,101 Abandoned
NCI E-275-2007-0-US-01 CD45, A Protein Tyrosine Phosphatase As A Therapeutic Target For Multiple Pathogenic Organisms US 60/644,931 Abandoned
NCI E-254-2005-2-EP-06 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS EP National Stage 07716564.5 Issued
NCI E-254-2005-2-EP-13 Improved IL-15 for Expression in Mammalian Cells EP DIV 11154217.1 Issued
NCI E-254-2005-2-IN-08 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS IN National Stage 4203/CHENP/2008 Issued
NCI E-254-2005-2-CN-16 CODON OPTIMIZED IL-15 AND IL-15R ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS CN DIV 201210119215.6 Issued
NCI E-254-2005-2-JP-09 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS JP National Stage 2008-550416 Issued
NCI E-254-2005-2-AU-02 Codon Optimized IL-15 and IL-15R Alpha Genes for Expression in Mammalian Cells AU National Stage 2007207785 Issued
NCI E-254-2005-2-CN-05 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS CN National Stage 200780003101.2 Issued
NCI E-254-2005-2-MX-10 Improved IL-15 for Expression in Mammalian Cells MX National Stage MX/a/2008/008940 Issued
NCI E-267-2005-0-PCT-02 Improved IL-12 for Expression in Mammalian Cells PCT PCT PCT/US2007/000825 Expired
NCI E-254-2005-2-PCT-01 Codon Optimized IL-15 and IL-15R-Alpha Genes for Expression in Mammalian Cells PCT PCT COMB PCT/US2007/000774 Expired
NCI E-059-2007-0-US-01 GP100-Specific T Cell Receptors and Related Materials and Methods of Use US 60/884,732 Abandoned
NCI E-286-2006-1-US-01 SCGB3A2 as a Growth Factor and Anti-Apoptotic Agent US 60/880,134 Abandoned
NCI E-254-2005-2-BR-03 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENES FOR EXPRESSION IN MAMMALIAN CELLS BR National Stage PI0707106-0 Pending
NIDDK E-021-2007-0-US-01 Methods to Identify Inhibitors of Cell Sickling US ORD 11/652,843 Abandoned
NIAID E-046-2007-0-US-01 Method for Rapid Detection of Clostridium Botulinum US 60/884,539 Abandoned
NIAMS E-011-2007-0-US-01 Blockade Of TL1A-DR3 Interactions To Ameliorate T-Cell Mediated Disease Pathology US 60/879,668 Abandoned
NCI E-249-2004-1-US-02 DNA-Based Vaccination of Retroviral-Infected Individuals Undergoing Treatment US National Stage 11/571,879 Abandoned
NCI E-050-2007-0-US-01 Methods of Determining the Prognosis of Hepatocellular Carcinoma US 60/884,052 Abandoned
NCI E-285-2006-1-US-01 Organ And Tumor Associated Endothelial Markers US 60/879,457 Abandoned
NCI E-083-2007-0-US-01 Use Of SLCOlB3 Genotyping To Predict A Survival Prognosis Of Prostate Cancer US 60/879,503 Abandoned
NCI E-347-2003-3-US-03 SUBSET OF COMPOSITE ANTIBODIES Of Hum Subgroup IV Light Chain Capable Of Binding To TAG-72 US CON 11/651,407 Expired
NCI E-181-2006-0-CN-17 MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Lung Cancer CN DIV 201410210166.6 Abandoned
NCI E-181-2006-0-DE-34 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer DE EP 12165740.7 Abandoned
NCI E-181-2006-0-EP-12 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer EP DIV 12165740.7 Abandoned
NCI E-181-2006-0-GB-35 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer GB EP 12165740.7 Abandoned
NCI E-181-2006-0-GB-33 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer GB EP 12165734.0 Abandoned
NCI E-181-2006-0-EP-11 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer EP DIV 12165734.0 Abandoned
NCI E-181-2006-0-DE-32 MicroRNA-based methods for the diagnosis, prognosis and treatment of lung cancer DE EP 12165734.0 Abandoned
NCI E-181-2006-0-DE-37 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer DE EP 12165748.0 Abandoned
NCI E-181-2006-0-IT-40 MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer IT EP 12165748.0 Abandoned